Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.
about
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cabozantinib As Salvage Therap ...... Thyroid Oncology Group Trial.
@en
Cabozantinib As Salvage Therap ...... Thyroid Oncology Group Trial.
@nl
type
label
Cabozantinib As Salvage Therap ...... Thyroid Oncology Group Trial.
@en
Cabozantinib As Salvage Therap ...... Thyroid Oncology Group Trial.
@nl
prefLabel
Cabozantinib As Salvage Therap ...... Thyroid Oncology Group Trial.
@en
Cabozantinib As Salvage Therap ...... Thyroid Oncology Group Trial.
@nl
P2093
P2860
P356
P1476
Cabozantinib As Salvage Therap ...... Thyroid Oncology Group Trial.
@en
P2093
John Wright
Jonas A de Souza
Komal Shah
Lori J Wirth
Manisha H Shah
Maria E Cabanillas
Michael E Menefee
Susan Geyer
P2860
P304
P356
10.1200/JCO.2017.73.0226
P407
P577
2017-08-17T00:00:00Z